UNCY vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

UNCY

54.0
AI Score
VS
UNCY Wins

CBIO

41.1
AI Score

Investment Advisor Scores

UNCY

54score
Recommendation
HOLD

CBIO

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric UNCY CBIO Winner
Revenue 675,000 4.16M CBIO
Net Income -14.57M -85.85M UNCY
Net Margin -2159.3% -2065.6% CBIO
Operating Income -4.20M -91.00M UNCY
ROE 96.6% -31.3% UNCY
ROA -53.6% -28.7% CBIO
Total Assets 27.20M 299.50M CBIO
Cash 24.33M 289.36M CBIO
Current Ratio 1.64 12.57 CBIO

Relative Price Performance (Last 90 Days)

UNCY 1M: -1.6% · 3M: -33.9% CBIO 1M: +14.2% · 3M: -16.2%

Current Technical Phase

UNCY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.6%), weak momentum, RSI 44

RSI (14): 44.0 · Price: $3.64

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $14.37

Fundamentals Snapshot

Metric UNCY CBIO
Market Cap — —
Forward P/E 2.5 -5.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — 1.0%
Operating Margin 0.0% -14.3%
EPS -1.72 -7.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UNCY is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.